metabolic health

What does the evidence say about Policosanol Lipids Meta-Analysis?

Updated October 2026

Quick Answer

Policosanol Lipids Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: The broad-spectrum of MetS is associated with obesity and characterized by some abnormalities such as NAFLD and dyslipidemia, which is characterized by the imbalance of lipids (i.e., total cholesterol, Low-Density Lipoprotein [LDL] cholesterol, triglycerides [TGs], and High-Density Lipoprotein [HDL] cholesterol) [,].

Key Takeaways

  • 01The broad-spectrum of MetS is associated with obesity and characterized by some abnormalities such as NAFLD and dyslipidemia, which is characterized by the imbalance of lipids (i.e., total cholesterol, Low-Density Lipoprotein [LDL] cholesterol, triglycerides [TGs], and High-Density Lipoprotein [HDL] cholesterol) [,]. [Teixeira Francisca S. (2023)]
  • 025 6 7 8 A study involving 50 overweight and obese patients, with BMI levels between 25 and 33 kg/m, revealed that, in these conditions, erythrocytes can be subjected to oxidative damage and present increased cholesterol content, lower concentrations of omega-3 fatty acids (FAs) and thus a decrease in membrane fluidity [,]. [Teixeira Francisca S. (2023)]
  • 03The anti-depressant bupropion has shown modest weight loss, while naltrexone (i.e., opioid addiction and alcoholism treatment) is not associated with weight reduction. [Teixeira Francisca S. (2023)]
  • 042 2 1 2 The prevalence of non-communicable diseases, such as obesity and type II diabetes, has been increasing in the European region, affecting both adults and children. [Teixeira Francisca S. (2023)]
The current Migaku evidence database contains 2 reusable source documents for Policosanol Lipids Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The broad-spectrum of MetS is associated with obesity and characterized by some abnormalities such as NAFLD and dyslipidemia, which is characterized by the imbalance of lipids (i.e., total cholesterol, Low-Density Lipoprotein [LDL] cholesterol, triglycerides [TGs], and High-Density Lipoprotein [HDL] cholesterol) [,]. [Teixeira Francisca S. (2023); evidence level 3] - 5 6 7 8 A study involving 50 overweight and obese patients, with BMI levels between 25 and 33 kg/m, revealed that, in these conditions, erythrocytes can be subjected to oxidative damage and present increased cholesterol content, lower concentrations of omega-3 fatty acids (FAs) and thus a decrease in membrane fluidity [,]. [Teixeira Francisca S. (2023); evidence level 3] - The anti-depressant bupropion has shown modest weight loss, while naltrexone (i.e., opioid addiction and alcoholism treatment) is not associated with weight reduction. [Teixeira Francisca S. (2023); evidence level 3] - 2 2 1 2 The prevalence of non-communicable diseases, such as obesity and type II diabetes, has been increasing in the European region, affecting both adults and children. [Teixeira Francisca S. (2023); evidence level 3] - In this study, we addressed various challenges associated with the consumption of functional lipids from the Ericerus pela (Chavannes), including unfavorable taste, insolubility in water, difficulty in oral intake, low bioavailability, and low psychological acceptance. [Liu Y (2023); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

GuideAshwagandha: What the Evidence Actually Says About Stress and CortisolLegacy library material — check the original sources.GuideMagnesium Glycinate benefits: what does the evidence sayLegacy library material — check the original sources.GuideProbiotics: What the Evidence Actually Supports (and What It Doesn't)Legacy library material — check the original sources.GuideL-Theanine: How It Works, What the Evidence Says, and How to Dose ItLegacy library material — check the original sources.DataPolicosanol Lipids Meta-Analysis Evidence TableLegacy library material — check the original sources.DataPolicosanol Lipid Profile Randomized Trial Evidence TableLegacy library material — check the original sources.DataGamma-Oryzanol Lipids Meta-Analysis Evidence TableLegacy library material — check the original sources.

Sources

  1. Novel Lipids to Regulate Obesity and Brain Function: Comparing Available Evidence and Insights from QSAR In Silico Models
  2. A New Strategy for Consumption of Functional Lipids from <i>Ericerus pela</i> (Chavannes): Study on Microcapsules and Effervescent Tablets Containing Insect Wax-Derived Policosanol.